Rare skin adverse reactions induced by osimertinib: a case report and literature review

Rare skin adverse reactions induced by osimertinib: a case report and literature review

Osimertinib is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) used in the treatment of EGFR mutation-positive advanced non-small cell lung cancer. Osimertinib-induced cutaneous vasculitis is a rare skin adverse reaction. We present a case study of a 49-year-...

Full description

Saved in:
Bibliographic Details
Main Authors: Ye Zhang, Mingzhu Ling, Min Wang, Ye Chen, Liting Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Oncology
Subjects:
adverse drug reaction
cutaneous vasculitis
osimertinib
EGFR-TKIs
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1523541/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items